HighTower Advisors
WGS icon

HighTower Advisors’s GeneDx Holdings WGS Stock Holding History

HighTower Advisors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,682
Closed -$349K – 3963
2025
Q4 		$349K Buy
+2,682
New +$368K ﹤0.01% 2924
2023
Q4 		– Sell
-237,948
Closed -$865K – 3871
2023
Q3 		$865K Buy
237,948
+29,361
+14% +$161K ﹤0.01% 1871
2023
Q2 		$1.24M Buy
208,587
+38,751
+23% +$307K ﹤0.01% 1630
2023
Q1 		$2.04M Buy
169,836
+154,150
+983% +$2.05M ﹤0.01% 1269
2022
Q4 		$134K Buy
+15,686
New +$346K ﹤0.01% 2889
2022
Q2 		– Sell
-8,983
Closed -$909K – 3572
2022
Q1 		$909K Sell
8,983
-3,511
-28% -$390K ﹤0.01% 1814
2021
Q4 		$1.84M Buy
12,494
+9,325
+294% +$2.08M ﹤0.01% 1406
2021
Q3 		$798K Buy
+3,169
New +$1.09M ﹤0.01% 1784
2021
Q2 		– Sell
-1,432
Closed -$703K – 3414
2021
Q1 		$703K Sell
1,432
-26,547
-95% -$13.8M ﹤0.01% 1771
2020
Q4 		$10.2M Buy
+27,979
New +$9.75M 0.04% 367

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HighTower Advisors's WGS Position: Q1 2026 in Review

HighTower Advisors sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 2,682 shares — an estimated $349K sold.

HighTower Advisors first reported a position in WGS in Q4 2020 and held it in 10 quarters. The position peaked at $10.2M in Q4 2020. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • HighTower Advisors reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 2,682 GeneDx Holdings shares in Q1 2026, an estimated $349K.
  • HighTower Advisors first reported a position in GeneDx Holdings in Q4 2020 and held it in 10 quarters.
  • HighTower Advisors's GeneDx Holdings position peaked at $10.2M in Q4 2020.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.